vTv Therapeutics Inc. Accounts Payable and Accrued Liabilities, Current
vTv Therapeutics Inc. (VTVT) had Accounts Payable and Accrued Liabilities, Current of $6.99 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable and Accrued Liabilities, Current $6.99M.
- 2026-03-31: Accounts Payable and Accrued Liabilities, Current $6.82M.
- 2025-12-31: Accounts Payable and Accrued Liabilities, Current $6.56M.
- 2025-09-30: Accounts Payable and Accrued Liabilities, Current $9.80M.
| Period end | Accounts Payable and Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $6.99M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $6.82M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $6.56M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $9.80M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $5.22M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $4.19M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $5.03M 10-K · filed 2026-03-10 |
| 2024-09-30 | $6.23M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $6.79M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $8.73M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $10.24M 10-K · filed 2025-03-20 |
| 2023-09-30 | $9.62M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $9.11M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $8.36M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $7.31M 10-K · filed 2024-03-13 |
| 2022-09-30 | $6.68M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $9.60M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $12.47M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $8.02M 10-K · filed 2023-03-06 |
| 2021-09-30 | $4.66M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $4.86M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $4.96M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $6.12M 10-K · filed 2022-03-29 |
| 2020-09-30 | $5.75M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $6.70M 10-Q · filed 2020-08-03 |
| 2020-03-31 | $7.39M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $7.07M 10-K · filed 2021-02-24 |
| 2019-09-30 | $6.90M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $8.33M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $6.24M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $7.70M 10-K · filed 2020-02-21 |
| 2018-09-30 | $8.96M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $13.14M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $11.30M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $13.90M 10-K · filed 2019-02-26 |
| 2017-09-30 | $10.12M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $10.73M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $11.11M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $11.41M 10-K · filed 2018-02-27 |
| 2016-09-30 | $10.16M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $9.49M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $7.96M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $6.63M 10-K · filed 2017-02-24 |
| 2015-09-30 | $5.24M 10-Q · filed 2015-11-13 |
| 2014-12-31 | $3.08M 10-K · filed 2016-03-04 |